Anzahl der Einträge: 6.
Artikel
Beckers, Thomas,
Mahboobi, Siavosh,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Maier, Thomas,
Ciossek, Thomas,
Baer, Thomas,
Kelter, Gerhard,
Fiebig, Heinz-Herbert und
Schmidt, Mathias
(2012)
Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases.
MedChemComm 3 (7), S. 829.
Volltext nicht vorhanden.
Mahboobi, Siavosh,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Ciossek, Thomas,
Baer, Thomas,
Maier, Thomas und
Beckers, Thomas
(2010)
Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity.
Journal of Medicinal Chemistry 53 (24), S. 8546-8555.
Volltext nicht vorhanden.
Mahboobi, Siavosh,
Dove, Stefan,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Ciossek, Thomas,
Baer, Thomas,
Maier, Thomas und
Beckers, Thomas
(2009)
Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases.
Journal of medicinal chemistry 52 (8), S. 2265-79.
Volltext nicht vorhanden.
Mahboobi, Siavosh,
Sellmer, Andreas,
Höcher, Heymo,
Garhammer, Christian,
Pongratz, Herwig,
Maier, Thomas,
Ciossek, Thomas und
Beckers, Thomas
(2007)
2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors.
Journal of Medicinal Chemistry 50 (18), S. 4405-4418.
Volltext nicht vorhanden.
Buchkapitel
Diese Liste wurde erzeugt am Thu Jan 9 20:14:48 2025 CET.